Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions

Creators: Capitanio, Selene; Bongioanni, Francesca; Piccardo, Arnoldo; Campus, Claudio; Gonella, Roberta; Tixi, Lucia; Naseri, Mehrdad; Pennone, Michele; Altrinetti, Vania; Buschiazzo, Ambra; Bossert, Irene; Fiz, Francesco; Bruno, Andrea; DeCensi, Andrea; Sambuceti, Gianmario; Morbelli, Silvia

Others:: Capitanio, Selene; Bongioanni, Francesca; Piccardo, Arnoldo; Campus, Claudio; Gonella, Roberta; Tixi, Lucia; Naseri, Mehrdad; Pennone, Michele; Altrinetti, Vania; Buschiazzo, Ambra; Bossert, Irene; Fiz, Francesco; Bruno, Andrea; Decensi, Andrea; Sambuceti, Gianmario; Morbelli, Silvia

Description

To compare 2-deoxy-2-((18)F)fluoro-D-glucose((18)F-FDG) and (18)F-sodium ((18)F-NaF) positron emission tomography/computed tomography (PET/CT) accuracy in breast cancer patients with clinically/radiologically suspected or known bone metastases.

Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions

Description

Additional details